These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 17961096)
1. Anti-IgE in allergic asthma and rhinitis: an update. Morjaria JB; Gnanakumaran G; Babu KS Expert Opin Biol Ther; 2007 Nov; 7(11):1739-47. PubMed ID: 17961096 [TBL] [Abstract][Full Text] [Related]
2. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Nowak D Respir Med; 2006 Nov; 100(11):1907-17. PubMed ID: 16949266 [TBL] [Abstract][Full Text] [Related]
3. A recombinant humanized anti-IgE monoclonal antibody (omalizumab) in the therapy of moderate-to-severe allergic asthma. D'Amato G; Piccolo A; Salzillo A; Noschese P; D'Amato M; Liccardi G Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):225-31. PubMed ID: 19075985 [TBL] [Abstract][Full Text] [Related]
4. Omalizumab: an effective anti-IgE treatment for allergic asthma and rhinitis. Casale TB; Drugs Today (Barc); 2004 Apr; 40(4):367-76. PubMed ID: 15190389 [TBL] [Abstract][Full Text] [Related]
5. Anti-IgE for chronic asthma in adults and children. Walker S; Monteil M; Phelan K; Lasserson TJ; Walters EH Cochrane Database Syst Rev; 2004; (3):CD003559. PubMed ID: 15266491 [TBL] [Abstract][Full Text] [Related]
7. Anti-IgE antibodies for the treatment of asthma. Buhl R Curr Opin Pulm Med; 2005 Jan; 11(1):27-34. PubMed ID: 15591885 [TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Vignola AM; Humbert M; Bousquet J; Boulet LP; Hedgecock S; Blogg M; Fox H; Surrey K Allergy; 2004 Jul; 59(7):709-17. PubMed ID: 15180757 [TBL] [Abstract][Full Text] [Related]
9. Anti-IgE therapy with omalizumab in asthma and allergic rhinitis. Dodig S; Richter D; Cepelak I; Benko B Acta Pharm; 2005 Jun; 55(2):123-38. PubMed ID: 16179127 [TBL] [Abstract][Full Text] [Related]
10. Omalizumab and the treatment of allergic rhinitis. Kaliner MA Curr Allergy Asthma Rep; 2004 May; 4(3):237-44. PubMed ID: 15056407 [TBL] [Abstract][Full Text] [Related]
11. [Omalizumab, an anti-IgE monoclonal antibody to treat severe asthma]. Michils A; Sternon J J Pharm Belg; 2006; 61(3):83-7. PubMed ID: 17058881 [TBL] [Abstract][Full Text] [Related]
12. Effects of treatment with anti-immunoglobulin E antibody omalizumab on airway inflammation in allergic asthma. Djukanović R; Wilson SJ; Kraft M; Jarjour NN; Steel M; Chung KF; Bao W; Fowler-Taylor A; Matthews J; Busse WW; Holgate ST; Fahy JV Am J Respir Crit Care Med; 2004 Sep; 170(6):583-93. PubMed ID: 15172898 [TBL] [Abstract][Full Text] [Related]
13. [Omalizumab, recombinant humanized monoclonal antibody anti-IgE -- new fields of studies on the therapeutic indications]. Kupryś-Lipińska I; Kuna P Pneumonol Alergol Pol; 2009; 77(1):43-51. PubMed ID: 19308909 [TBL] [Abstract][Full Text] [Related]
14. Omalizumab: efficacy in allergic disease. Spector S Panminerva Med; 2004 Jun; 46(2):141-8. PubMed ID: 15507883 [TBL] [Abstract][Full Text] [Related]
15. Role of anti-IgE monoclonal antibody (omalizumab) in the treatment of bronchial asthma and allergic respiratory diseases. D'Amato G Eur J Pharmacol; 2006 Mar; 533(1-3):302-7. PubMed ID: 16464445 [TBL] [Abstract][Full Text] [Related]
16. World Asthma and COPD Forum. Clinical trial results with omalizumab. D'Amato G IDrugs; 2008 Jul; 11(7):489-92. PubMed ID: 18600594 [No Abstract] [Full Text] [Related]
20. Omalizumab in the treatment of severe asthma: efficacy and current problems. Pelaia G; Renda T; Romeo P; Busceti MT; Maselli R Ther Adv Respir Dis; 2008 Dec; 2(6):409-21. PubMed ID: 19124386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]